FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/077783 [Registered on: 06/12/2024] Trial Registered Prospectively
Last Modified On: 03/12/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Yoga & Naturopathy
Diagnostic
Preventive 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To evaluate the role of Ayurvedic medicine and lifestyle in management of post-menopausal women 
Scientific Title of Study   To evaluate the role of Ayurvedic medicine and lifestyle in management of post-menopausal women 
Trial Acronym  PM-01 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Garima Kachhawa 
Designation  Professor 
Affiliation  All India Institute of Medical Sciences, New Delhi 
Address  Room Number-701, 7th floor, MCH Block, AIIMS,New Delhi-110029

New Delhi
DELHI
110029
India 
Phone  09868246702  
Fax    
Email  garimakachhawa2012@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr GARIMA KACHHAWA 
Designation  Professor 
Affiliation  All India Institute of Medical Sciences, New Delhi 
Address  Room Number-701, 7th floor, MCH block, AIIMS, New Delhi-110029


DELHI
110029
India 
Phone  09868246702  
Fax    
Email  garimakachhawa2012@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Garima Kachhawa 
Designation  Professor 
Affiliation  All India Institute of Medical Sciences, New Delhi 
Address  Room Number-701, 7th floor, MCH Block, AIIMS, New Delhi-110029

New Delhi
DELHI
110029
India 
Phone  09868246702  
Fax    
Email  garimakachhawa2012@gmail.com  
 
Source of Monetary or Material Support  
ICMR,NEW DELHI 
 
Primary Sponsor  
Name  INDIAN COUNCIL OF MEDICAL RESEARCH 
Address  ICMR, ANSARI NAGAR, NEW DELHI 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Garima Kachhawa  AIIMS, New Delhi  Room Number-701, 7th floor, MCH Block, AIIMS, New Delhi-110029
New Delhi
DELHI 
09868246702

garimakachhawa2012@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E349||Endocrine disorder, unspecified. Ayurveda Condition: RAJONASAH (KEVALAVATA), (2) ICD-10 Condition:E349||Endocrine disorder, unspecified. Ayurveda Condition: RAJONASAH (KEVALAVATA),  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Mukta shukti-pishti, Reference: Ayurveda, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 250(mg), Frequency: bd, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(2) Medicine Name: 6 Months, Reference: No, Route: NA, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
2Comparator Arm (Non Ayurveda)-Standard Treatment (Tab Calcium 500 mg BD))Group II: Standard treatment and physical activity plan (home-based mild-moderate exercise and walking for 15-45 minutes)
3Intervention ArmDrugClassical(1) Medicine Name: Shatawari churn , Reference: Ayurveda, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 6(g), Frequency: bd, Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(2) Medicine Name: 6 Months, Reference: , Route: , Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
(3) Medicine Name: 6 Months, Reference: , Route: , Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: (), Frequency: , Bhaishajya Kal: , Duration: , anupAna/sahapAna: No, Additional Information:
 
Inclusion Criteria  
Age From  45.00 Year(s)
Age To  65.00 Year(s)
Gender  Female 
Details  1. Postmenopausal women aged 45 to 65 years
2. Postmenopausal women with natural, induced or surgical menopause
3. Willing to participate in the study
 
 
ExclusionCriteria 
Details  1. Women with T score less than -2.5 of BMD
2. Women with severe menopausal symptoms including stroke, cardiovascular diseases requiring pharmacological treatment
3. Chronic comorbidities requiring treatment
4. Any condition preventing walking/exercise
5. Not willing for follow-up
6. Any condition on PI discretion
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Alternation 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
1. We expect from this study that the cure rate of menopausal symptoms with Ayurvedic therapies is comparable to standard non-hormonal treatment.
 
3,6 and 12 months 
 
Secondary Outcome  
Outcome  TimePoints 
1. The study will provide us the acceptability of Ayurvedic treatment & Yoga for menopausal symptoms.
2. We will find out the prevalence of various menopausal symptoms, NCD, osteoporosis & risk factors for CVD in Indian menopausal women.
3. We will find out the level of various inflammatory markers (NLR, PLR & CRP) in Indian menopausal women.
 
0,3,6 & 12 months 
 
Target Sample Size   Total Sample Size="250"
Sample Size from India="250" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   01/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

i.   Rationale/Gaps in existing knowledge: Menopause is an important milestone in a woman’s life when she experiences a variety of physical, psychosocial and sexual symptoms. Many of these women have existing NCD which precludes use of MHT. Presently there are only a few effective options for menopausal symptoms in women who are reluctant to use MHT or MHT is contraindicated. There is a need to explore various non-hormonal therapies to treat menopausal symptoms. Ayurvedic therapies remain unexplored to address this issue.

      ii.      Novelty: To compare ayurvedic medicine and Yoga with standard treatment and physical activity plan using RCT is a novel concept.

    iii.   Objectives: This study will evaluate efficacy of oral Ayurvedic medicine (Shatawari churn 6 gm twice daily and Mukta shukti-pishti 250 mg twice daily) and Yoga in control of menopausal symptoms in women aged 45-65 years as compared to standard treatment and physical activity plan. It will also assess acceptance and compliance of women to Ayurvedic therapies.

    iv.      Methods: This study will recruit a total of 250 postmenopausal women aged 45-65 years who will be assessed for menopausal symptoms using SF-36 questionnaire. All women will undergo screening for NCD, osteoporosis, breast and cervical cancer. Women will be randomized (1:1) into two groups. Group 1 will receive Ayurvedic medicines and Yoga for 6 months and Group 2 will receive standard treatment and physical activity plan as per hospital protocol. Follow-up will be at 1, 3, 6 and 12-months.

    v.      Expected Outcome: Ayurvedic treatment and Yoga is non-inferior to standard treatment and physical activity plan in the management of menopausal symptoms.

 
Close